FBXW11 CRISPR Knockout HepG2 Stable Cell Line-T1-5

Description

This Hep G2 parental cell line features a stable knockout of FBXW11 - involved in the ubiquitin-proteasome system, influencing protein degradation and playing roles in cell cycle control, signal transduction, and apoptosis - mediated through CRISPR/Cas9 genome editing technology. This knockout allows for detailed exploration of FBXW11s role in hepatocellular function and carcinogenesis, providing insights into how its absence affects cell proliferation, survival, and drug responses. Such a model is invaluable for studying liver metabolism and oncology, offering a controlled environment to test potential therapeutic targets and the efficacy of drugs that interact with cellular protein regulation pathways. The T1-5 designation indicates a specific clone or variant within this engineered line, ensuring consistent and reproducible results in research focused on liver cancer and related metabolic disorders.